Anette Blak Grossi

Anette Blak Grossi is a seasoned Senior Scientist with extensive experience in nonclinical safety and pharmacology. Currently at Novo Nordisk since October 2021, prior roles include Senior Scientist at Orphazyme A/S and Senior Client Manager at Charles River Laboratories. Anette has a strong background in toxicology and has managed various projects involving CROs while ensuring regulatory compliance. Additional experience encompasses scientific management and advisory roles in business development and teaching, including a significant academic background with a Ph.D. in Veterinary Pathology from the University of Copenhagen. Anette's expertise includes overseeing drug development projects and offering scientific insights into veterinary pathology.